| Members |
targetComponentId |
| Patient immunosuppressed |
Patient immunosuppressed (finding) |
| Patient refuses hormone replacement therapy |
Hormone replacement therapy declined |
| patient passé en revu |
Patient review (procedure) |
| Patient reviewed |
Patient review (procedure) |
| Patient reviewed at hospital |
Review at hospital (procedure) |
| Patient reviewed at hospital |
Review at hospital (procedure) |
| Patient triggered inspiratory assistance |
Pressure support ventilation (regime/therapy) |
| Patient written birth plan |
Patient written birth plan (record artifact) |
| Pauciarticular juvenile rheumatoid arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Pauciarticular onset juvenile chronic arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| environnement paisible |
Peaceful environment (finding) |
| Peach - dietary |
Peach (substance) |
| aliment : arachide |
Peanut (substance) |
| Pear - dietary |
Pear (substance) |
| Pectobacterium chrysanthemi |
Dickeya chrysanthemi (organism) |
| Pectoralis major myocutaneous flap plus rib |
Pectoralis major osteomyocutaneous flap of rib |
| Pedicle flap reconstruction - action |
Flap reconstruction - action |
| Pedicle transverse rectus abdominus flap |
Pedicle transverse rectus abdominis myocutaneous flap (substance) |
| Pediculus humanus humanus |
Pediculus humanus |
| Pediococcus urinae-equi |
Aerococcus urinaeequi (organism) |
| Pegaptanib 0.3mg intravitreal injection solution 1mL prefilled syringe |
Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection |
| Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe |
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
| Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
| Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
| Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
| Peginterferon alfa-2b 120micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 50micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
| Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
| Pegvisomant 30mg powder for injection solution vial |
Pegvisomant 20 mg powder for solution for injection vial |
| Pelvic somatic dysfunction |
Somatic dysfunction |
| Penetrating injury caused by glass |
Penetrating injury caused by glass fragment |
| Penetrating injury due to glass |
Penetrating injury caused by glass fragment |
| Penicillin G benzathine 300,000unit/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 1200000unt/2mL suspension |
Product containing only benzylpenicillin (medicinal product) |
| Penicillin g benzathine 150000iu/penicillin g procaine 150000iu powder for injection solution vial |
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection suspension 10mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 300,000unt/mL injection suspension 1mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g benzathine 600,000unt/mL injection suspension 1mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 20mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 2mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| Penicillin g benzathine 600,000unt/mL injection suspension 4mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
| Penicillin g benzathine 900000iu/penicillin g procaine 300000iu powder for injection solution vial |
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection |
| Penicillin g procaine 600,000unt/mL injection suspension 1mL vial |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin g procaine 600,000unt/mL injection suspension 4mL vial |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
| Penicillin overdose |
Penicillin antibacterial overdose (disorder) |
| Penicillin v potassium 500mg |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
| Penicillin v potassium 500mg tablet |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
| Penicillium mycetogenum |
Penicillium mycetomagenum |
| Penicillium patulum |
Penicillium griseofulvum |
| Penicillium rubrum |
Talaromyces purpureogenus (organism) |
| Penicillium rubrum toxicosis |
Penicillium purpurogenum toxicosis (disorder) |
| Penicilloyl G extract |
Product containing benzylpenicillin (medicinal product) |
| Penicilloyl V extract |
Phenoxymethylpenicillin-containing product |
| Pentamidine isethionate 300mg injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
| Pentamidine isethionate 300mg/5mL nebulizer solution |
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Pentamidine isethionate 300mg/vial injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
| Pentasa 1g/100mL retention enema |
Mesalazine only product in rectal dose form |
| Pentastarch 10% infusion solution bottle |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10% injection solution bag |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10g/100mL conventional release solution for infusion 500mL bag |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10g/100mL injection |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 10g/100mL intravenous solution 500mL bag |
Pentastarch 100 mg/mL solution for injection |
| Pentastarch 6% in sodium chloride 7.2% conventional release solution for injection |
Product containing only pentastarch (medicinal product) |
| Pentastarch 6% in sodium chloride 7.2% intravenous infusion |
Product containing only pentastarch (medicinal product) |
| Pentastarch 6% infusion solution bottle |
Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Pentastarch allergy |
Non-allergic hypersensitivity to pentastarch |
| Pentobarbital sodium 18.2mg/5ml elixir |
Product containing precisely pentobarbital sodium 3.64 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Pentobarbital sodium 20mg/5ml elixir |
Pentobarbital sodium 4 mg/mL oral solution |
| Pentose shunt pathway |
Pentose shunt pathway |
| Pentostatin 10mg injection |
Pentostatin 10 mg powder for solution for injection vial |
| Pentosyltransferase |
Pentosyltransferase |
| République démocratique populaire du Yémen |
Yemen (geographic location) |
| Pepsin specific extract |
Product containing pepsin A (medicinal product) |
| Peptic reflux disease |
Gastro-esophageal reflux disease with esophagitis |
| Peptide hydrolase |
Peptide hydrolase |
| Peptostreptococcus hydrogenalis |
Anaerococcus hydrogenalis (organism) |
| Peptostreptococcus lactolyticus |
Anaerococcus lactolyticus (organism) |
| Peptostreptococcus magnus |
Finegoldia magna (organism) |
| Peptostreptococcus octavius |
Anaerococcus octavius (organism) |
| Peptostreptococcus parvulus |
Lancefieldella parvula |
| Peptostreptococcus prevotii |
Anaerococcus prevotii (organism) |
| Peptostreptococcus productus |
Blautia producta |
| Peptostreptococcus vaginalis |
Anaerococcus vaginalis (organism) |
| Perceptual disturbance due to alcohol withdrawal |
Perceptual disturbance due to alcohol withdrawal (disorder) |
| Percussion vibrator technique |
Osteopathic combined treatment method (procedure) |
| Perfluoroalkylpolyether 50%/polytetrafluoroethylene 50% topical paste |
Perfluoroalkylpolyether and polytetrafluoroethylene only product |
| Perflutren 2mL solution vial |
Perflutren only product |
| Perforation of root canal space due to endodontic treatment |
Perforation of root canal wall due to endodontic procedure |
| Pergolide 0.05mg tablet |
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) |
| Pergolide 0.25mg tablet |
Pergolide (as pergolide mesilate) 250 microgram oral tablet |
| Pergolide 1000micrograms tablet |
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
| Pergolide mesylate 0.05mg tablet |
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug) |
| Pergolide mesylate 0.25mg |
Pergolide (as pergolide mesilate) 250 microgram oral tablet |
| Perifolliculitis of the scalp |
Perifolliculitis capitis abscedens et suffodiens |
FHIR